Article Text

Download PDFPDF
Tiotropium reduced exacerbations but not rate of FEV1 decline in patients with COPD using other respiratory medications

Statistics from Altmetric.com

Footnotes

  • Source of funding: Boehringer Ingelheim and Pfizer.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.